NovaBridge Biosciences (NBP) Income towards Parent Company (2019 - 2025)

NovaBridge Biosciences (NBP) has reported Income towards Parent Company for 5 consecutive years, with -$72.9 million the latest figure, recorded in Q4 2025.

• Quarterly Income towards Parent Company fell 628.11% year-over-year to -$72.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$88.3 million (down 1380.63% YoY) and the FY2024 annual result came in at $27.5 million, up 1560668.18% from the prior year.
• Income towards Parent Company declined to -$72.9 million in Q4 2025 per NBP's latest filing, from -$6.8 million in the prior quarter.
• Over the last five years, Income towards Parent Company for NBP reached as high as $13.8 million in Q4 2024 and fell as low as -$72.9 million in Q4 2025.
• A 3-year average of -$8.1 million and a median of -$1.6 million in 2023 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2024 — Income towards Parent Company surged 377.78% — and 2025, when it sank 6115455.56%.
• Year by year, Income towards Parent Company stood at -$90.0 in 2023, then soared by 15328988.89% to $13.8 million in 2024, then tumbled by 628.11% to -$72.9 million in 2025.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$72.9 million, -$6.8 million, and -$5.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.